ConductScience.org, home

Paper35632575

An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.

Facciolà A and 3 others. Vaccines (Basel), 2022. Cited by 231 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Papers, record 35632575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35632575

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
231
iCite
Relative citation ratio, by iCite
19.6
iCite
Revised in PubMed
2022-07-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Facciolà AAlessiohttps://orcid.org/0000-0002-6801-237X
2Visalli GGiuseppahttps://orcid.org/0000-0002-9072-1148
3Laganà AAntonio
4Di Pietro AAngela

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References212

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
223,142,589Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.Vaccine2012https://conductscience.org/library/papers/23142589PubMed
316,043,410Revisiting Freund's incomplete adjuvant for vaccines in the developing world.Trends Parasitol2005https://conductscience.org/library/papers/16043410PubMed
418,650,390Molecular and cellular signatures of human vaccine adjuvants.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18650390PubMed
532,971,761Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants.Vaccines (Basel)2020https://conductscience.org/library/papers/32971761PubMed
620,844,205The capacity to induce cross-presentation dictates the success of a TLR7 agonist-conjugate vaccine for eliciting cellular immunity.J Immunol2010https://conductscience.org/library/papers/20844205PubMed
732,318,915Vaccine confidence in the time of COVID-19.Eur J Epidemiol2020https://conductscience.org/library/papers/32318915PubMed
824,390,332Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques.J Virol2014https://conductscience.org/library/papers/24390332PubMed
916,369,026A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity.Infect Immun2006https://conductscience.org/library/papers/16369026PubMed
1021,918,512The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus.Nature2011https://conductscience.org/library/papers/21918512PubMed
1128,985,943No evidence of DNA damage by co-exposure to extremely low frequency magnetic fields and aluminum on neuroblastoma cell lines.Mutat Res Genet Toxicol Environ Mutagen2017https://conductscience.org/library/papers/28985943PubMed
1221,995,388Oil-in-water emulsion adjuvant with influenza vaccine in young children.N Engl J Med2011https://conductscience.org/library/papers/21995388PubMed
1322,065,672Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans.J Exp Med2011https://conductscience.org/library/papers/22065672PubMed
1432,188,383A Comprehensive Insight Towards Pharmaceutical Aspects of Graphene Nanosheets.Curr Pharm Biotechnol2020https://conductscience.org/library/papers/32188383PubMed
1533,053,910Classical Examples of the Concept of the ASIA Syndrome.Biomolecules2020https://conductscience.org/library/papers/33053910PubMed
1626,897,363The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models.Parasit Vectors2016https://conductscience.org/library/papers/26897363PubMed
1725,692,975Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo.Nat Commun2015https://conductscience.org/library/papers/25692975PubMed
1826,555,265Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.J Biol Chem2016https://conductscience.org/library/papers/26555265PubMed
1922,619,554Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.Int J Nanomedicine2012https://conductscience.org/library/papers/22619554PubMed
201,987,271Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.J Immunol1991https://conductscience.org/library/papers/1987271PubMed
2121,697,806Ten great public health achievements--worldwide, 2001-2010.MMWR Morb Mortal Wkly Rep2011https://conductscience.org/library/papers/21697806PubMed

See all 212 references

Cited by160

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.

PMIDTitleJournalYearIn PapersSource
42,663,142Clinical and public health economic impact of rapid strain-matched vaccination in influenza pandemic mitigation: A UK-like population dynamic transmission model.Hum Vaccin Immunother2026https://conductscience.org/library/papers/42663142PubMed
42,654,751The Role of Adjuvant Nonavalent HPV Vaccination After LLETZ in Patients with Isolated CIN2: A Controlled Cohort Study.Pathogens2026https://conductscience.org/library/papers/42654751PubMed
42,654,300Dietary Aluminium Exposure and Human Health: Sources, Bioavailability, Toxicokinetics, and Health Risk Assessment.Nutrients2026https://conductscience.org/library/papers/42654300PubMed
42,613,385Proteome conserved multi-epitope-based vaccine construct against Nipah virus.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42613385PubMed
42,598,270Mincle receptor agonist UM-1098 and TLR4 agonist INI-2002 combination adjuvant enhances Th1 responses and provides protection against Mycobacterium tuberculosis challenge in mice.Vaccine X2025https://conductscience.org/library/papers/42598270PubMed
42,589,673Broad-Spectrum Multi-Epitope Design Targeting Conserved Hantavirus Glycoproteins (Gn/Gc): Chimeric Antigen Engineering and Structural Mapping.Int J Mol Sci2026https://conductscience.org/library/papers/42589673PubMed
42,541,679Immunoinformatics-driven multi-epitope vaccine design as a promising strategy against multidrug-resistant pathogens: a comprehensive review.Folia Microbiol (Praha)2026https://conductscience.org/library/papers/42541679PubMed
42,459,443Assessment of Immunogenicity of Multi-Epitope DNA Vaccine Encoding CDPK3, ROP22 & MIC8 of Toxoplasma gondii Adjuvanted with IL-12 against Acute and Chronic Toxoplasmosis in BALB/c Mice.Iran J Parasitol2026https://conductscience.org/library/papers/42459443PubMed
42,455,409Smart nanoparticle vaccines integrate nanotechnology artificial intelligence and immunoengineering for precision immunization.Discov Nano2026https://conductscience.org/library/papers/42455409PubMed
42,347,646Chimeric Pathogen-Associated Molecular Patterns (PAMPs) as Vaccine Adjuvants.Vaccines (Basel)2026https://conductscience.org/library/papers/42347646PubMed
42,347,631Development and Preliminary Mechanistic Evaluation of a Novel Liposomal QS-21 and CpG ODNs Adjuvant System for Enhancing Vaccine Immunogenicity.Vaccines (Basel)2026https://conductscience.org/library/papers/42347631PubMed
42,347,628Viral Vaccine Adjuvant Strategies for Shaping Durable Immunity Across the Human Lifespan.Vaccines (Basel)2026https://conductscience.org/library/papers/42347628PubMed
42,344,914From Jenner to genomics: the unfolding future of vaccinology.Front Immunol2026https://conductscience.org/library/papers/42344914PubMed
42,340,354Salmonella-derived OMVs as a vaccine platform for Riemerella anatipestifer outer membrane proteins to prevent infection in ducks.Appl Environ Microbiol2026https://conductscience.org/library/papers/42340354PubMed
42,238,579An engineered intradermal microneedle-array device enhances the cellular immune responses in a guinea pig model.Front Immunol2026https://conductscience.org/library/papers/42238579PubMed
42,220,545Nano-adjuvants enhance the immunogenicity and safety of infectious bursal disease virus vaccines: a comprehensive review.Front Immunol2026https://conductscience.org/library/papers/42220545PubMed
42,196,252Vaccine Adjuvants and Delivery Systems: A Comprehensive Review.Int J Mol Sci2026https://conductscience.org/library/papers/42196252PubMed
42,176,436Evaluation of EcoCRM, virus-like particles, and mRNA as vaccine platforms against Borrelia burgdorferi.Vaccine2026https://conductscience.org/library/papers/42176436PubMed
42,129,077Proteomic Analysis of Influenza.Adv Exp Med Biol2026https://conductscience.org/library/papers/42129077PubMed
42,075,186From Classical Bacterins to Recombinant Vaccines: Critical Aspects of the Immune Response in Ruminants.Microorganisms2026https://conductscience.org/library/papers/42075186PubMed

See all 160 cited by

Genes37

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE1,636PubTator's text mininghttps://conductscience.org/library/genes/1636NCBI Gene
BTG310,950PubTator's text mininghttps://conductscience.org/library/genes/10950NCBI Gene
CASP1834PubTator's text mininghttps://conductscience.org/library/genes/834NCBI Gene
CCL256,370PubTator's text mininghttps://conductscience.org/library/genes/6370NCBI Gene
CCL46,351PubTator's text mininghttps://conductscience.org/library/genes/6351NCBI Gene
CCL56,352PubTator's text mininghttps://conductscience.org/library/genes/6352NCBI Gene
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
CXCL83,576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
FCGR3A2,214PubTator's text mininghttps://conductscience.org/library/genes/2214NCBI Gene
HLA-A3,105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-DQB13,119PubTator's text mininghttps://conductscience.org/library/genes/3119NCBI Gene
HLA-DRB13,123PubTator's text mininghttps://conductscience.org/library/genes/3123NCBI Gene
IFIH164,135PubTator's text mininghttps://conductscience.org/library/genes/64135NCBI Gene
IFNA13,439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNG3,458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL12B3,593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL183,606PubTator's text mininghttps://conductscience.org/library/genes/3606NCBI Gene
IL1B3,553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene

See all 37 genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35632575

GET https://conductscience.org/api/papers/v1/35632575/references?page=2